| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2870873 | The Annals of Thoracic Surgery | 2016 | 7 Pages |
Abstract
EA is associated with improved nutritional status for patients undergoing neoadjuvant therapy for esophageal cancer. However, adverse events and suboptimal use are common. Esophagectomy outcomes were similar for patients with and without EA. These results support judicious patient selection for EA, expedited neoadjuvant therapy, and close collaboration with nutritionists.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mary E. MD, MA, Eric J. MD, Emily A. MD, Yinin MD, Christine L. MD, MBA, James M. MD, MSCI, Timothy L. PhD, Benjamin D. MD, MPH,